-
effectivehealthcare.ahrq.gov/sites/default/files/schwitzer_eccs2012.pdf
July 23, 2012 - excerpt comes from
an article, “Cancer Society Casts Doubt on Value of
Prostate
Cancer Test,”1 … His cancer was
removed. His impotence is being managed. … o The lung lesions led to major lung surgery, which detected no
malignancy: “I awoke in the recovery … Slide 17: Patient Viewpoints
on Cancer Screening
Controversies
(2 of 2)
• “Dr. … too many false positives (suspicious spots that
turn
out,
upon
biopsy,
to be nothing) and tumors
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2010_MaskedStats_Core_V2.PDF
January 01, 2010 - W MCC 18,194 0.13%
181: RESPIRATORY NEOPLASMS W CC 21,604 0.16%
182: RESPIRATORY NEOPLASMS W/O CC/ … & URETER PROCEDURES FOR NON-NEOPLASM W CC 11,021 0.08%
661: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM … ; other and unspecified primary 3,016 0.02%
42: Secondary malignancies 88,786 0.64%
43: Malignant neoplasm … 19,548 0.14%
45: Maintenance chemotherapy; radiotherapy 63,755 0.46%
46: Benign neoplasm of uterus … 76,963 0.55%
47: Other and unspecified benign neoplasm 63,891 0.46%
48: Thyroid disorders 19,799 0.14%
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2010_MaskedStats_Core_V2_Weighted.PDF
January 01, 2010 - W MCC 44,035 0.12%
181: RESPIRATORY NEOPLASMS W CC 51,926 0.14%
182: RESPIRATORY NEOPLASMS W/O CC/ … ; other and unspecified primary 7,842 0.02%
42: Secondary malignancies 214,010 0.57%
43: Malignant … neoplasm without specification of site 8,163 0.02%
44: Neoplasms of unspecified nature or uncertain … behavior 46,978 0.13%
45: Maintenance chemotherapy; radiotherapy 158,352 0.42%
46: Benign neoplasm … of uterus 171,187 0.46%
47: Other and unspecified benign neoplasm 152,830 0.41%
48: Thyroid disorders
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2011_MaskedStats_Core_V2.PDF
January 01, 2011 - W MCC 17,306 0.12%
181: RESPIRATORY NEOPLASMS W CC 20,773 0.15%
182: RESPIRATORY NEOPLASMS W/O CC/ … PROCEDURES FOR NEOPLASM W/O CC/MCC 9,902 0.07%
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC … ; other and unspecified primary 3,033 0.02%
42: Secondary malignancies 87,140 0.63%
43: Malignant neoplasm … 19,198 0.14%
45: Maintenance chemotherapy; radiotherapy 63,512 0.46%
46: Benign neoplasm of uterus … 68,796 0.49%
47: Other and unspecified benign neoplasm 60,810 0.44%
48: Thyroid disorders 18,895 0.14%
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2011_MaskedStats_Core_V2_Weighted.PDF
January 01, 2011 - W MCC 41,892 0.11%
181: RESPIRATORY NEOPLASMS W CC 49,904 0.14%
182: RESPIRATORY NEOPLASMS W/O CC/ … ; other and unspecified primary 8,065 0.02%
42: Secondary malignancies 210,548 0.57%
43: Malignant … neoplasm without specification of site 8,609 0.02%
44: Neoplasms of unspecified nature or uncertain … behavior 45,768 0.12%
45: Maintenance chemotherapy; radiotherapy 159,601 0.43%
46: Benign neoplasm … of uterus 149,385 0.40%
47: Other and unspecified benign neoplasm 144,440 0.39%
48: Thyroid disorders
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2012_MaskedStats_Core_V2.PDF
January 01, 2012 - W MCC 17,087 0.13%
181: RESPIRATORY NEOPLASMS W CC 19,272 0.14%
182: RESPIRATORY NEOPLASMS W/O CC/ … PROCEDURES FOR NEOPLASM W/O CC/MCC 10,069 0.07%
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W … ; other and unspecified primary 2,917 0.02%
42: Secondary malignancies 83,841 0.62%
43: Malignant neoplasm … 18,475 0.14%
45: Maintenance chemotherapy; radiotherapy 60,731 0.45%
46: Benign neoplasm of uterus … 57,767 0.43%
47: Other and unspecified benign neoplasm 57,065 0.42%
48: Thyroid disorders 16,796 0.12%
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2012_MaskedStats_Core_V2_Weighted.PDF
January 01, 2012 - W MCC 42,405 0.12%
181: RESPIRATORY NEOPLASMS W CC 47,403 0.13%
182: RESPIRATORY NEOPLASMS W/O CC/ … ; other and unspecified primary 7,786 0.02%
42: Secondary malignancies 206,465 0.57%
43: Malignant … neoplasm without specification of site 9,218 0.03%
44: Neoplasms of unspecified nature or uncertain … behavior 45,048 0.12%
45: Maintenance chemotherapy; radiotherapy 157,338 0.43%
46: Benign neoplasm … of uterus 127,128 0.35%
47: Other and unspecified benign neoplasm 138,602 0.38%
48: Thyroid disorders
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2013_MaskedStats_Core_Weighted.PDF
January 01, 2013 - W MCC 42,076 0.12%
181: RESPIRATORY NEOPLASMS W CC 43,622 0.12%
182: RESPIRATORY NEOPLASMS W/O CC/ … ; other and unspecified primary 7,609 0.02%
42: Secondary malignancies 200,515 0.56%
43: Malignant … neoplasm without specification of site 9,147 0.03%
44: Neoplasms of unspecified nature or uncertain … behavior 42,887 0.12%
45: Maintenance chemotherapy; radiotherapy 158,964 0.45%
46: Benign neoplasm … of uterus 113,052 0.32%
47: Other and unspecified benign neoplasm 132,169 0.37%
48: Thyroid disorders
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2012_MaskedStats_Core.PDF
January 01, 2012 - of head and neck 186 0.01%
13: Cancer of stomach 14 0.00%
14: Cancer of colon 79 0.00%
15: Cancer … of uterus 14 0.00%
26: Cancer of cervix 15 0.00%
27: Cancer of ovary 213 0.01%
28: Cancer of other … and unspecified primary 1,422 0.04%
42: Secondary malignancies 1,283 0.04%
43: Malignant neoplasm … 0.06%
45: Maintenance chemotherapy; radiotherapy 32,741 1.02%
46: Benign neoplasm of uterus 48 0.00% … 47: Other and unspecified benign neoplasm 5,936 0.19%
48: Thyroid disorders 917 0.03%
49: Diabetes
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2012_MaskedStats_Core_Weighted.PDF
January 01, 2012 - of head and neck 264 0.00%
13: Cancer of stomach <= 50 *.**%
14: Cancer of colon 109 0.00%
15: Cancer … of uterus <= 50 *.**%
26: Cancer of cervix <= 50 *.**%
27: Cancer of ovary 300 0.00%
28: Cancer of … ; other and unspecified primary 2,027 0.03%
42: Secondary malignancies 1,825 0.03%
43: Malignant neoplasm … 0.04%
45: Maintenance chemotherapy; radiotherapy 46,804 0.70%
46: Benign neoplasm of uterus 66 0.00% … 47: Other and unspecified benign neoplasm 8,362 0.13%
48: Thyroid disorders 1,288 0.02%
49: Diabetes
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2015Q1Q3_Dx_Pr_Grps.PDF
November 08, 2017 - W MCC 6,562 0.12%
181: RESPIRATORY NEOPLASMS W CC 5,516 0.10%
182: RESPIRATORY NEOPLASMS W/O CC/MCC … PROCEDURES FOR NEOPLASM W/O CC/MCC 3,442 0.06%
659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC … ; other and unspecified primary 1,151 0.02%
42: Secondary malignancies 28,569 0.53%
43: Malignant neoplasm … 6,336 0.12%
45: Maintenance chemotherapy; radiotherapy 22,662 0.42%
46: Benign neoplasm of uterus … 15,522 0.29%
47: Other and unspecified benign neoplasm 18,092 0.34%
48: Thyroid disorders 3,856 0.07%
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2006_MaskedStats_Core_Weighted.PDF
January 01, 2006 - of skin 5757 0.01
24: Cancer of breast 84518 0.21
25: Cancer of uterus 38527 0.10
26: Cancer of cervix … Cancer of prostate 89010 0.23
30: Cancer of testis 1869 0.00
31: Cancer of other male genital organs … 802 0.00
32: Cancer of bladder 38773 0.10
33: Cancer of kidney and renal pelvis 44586 0.11
34: Cancer … , other Unspecified primary 7607 0.02
42: Secondary malignancies 241780 0.61
43: Malignant neoplasm … neoplasm of uterus 205200 0.52
47: Other unspecified benign neoplasm 165184 0.42
48: Thyroid disorders
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2013_MaskedStats_Core_Weighted.PDF
January 01, 2013 - W MCC 42,965 0.12%
181: RESPIRATORY NEOPLASMS W CC 43,265 0.12%
182: RESPIRATORY NEOPLASMS W/O CC/ … ; other and unspecified primary 7,230 0.02%
42: Secondary malignancies 195,925 0.55%
43: Malignant … neoplasm without specification of site 8,950 0.03%
44: Neoplasms of unspecified nature or uncertain … behavior 42,635 0.12%
45: Maintenance chemotherapy; radiotherapy 157,135 0.44%
46: Benign neoplasm … of uterus 104,565 0.29%
47: Other and unspecified benign neoplasm 126,435 0.36%
48: Thyroid disorders
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-decision-support-tools_research-protocol.pdf
November 12, 2013 - (breast, colon,
lung and prostate), and according to high prevalence versus rare cancers. … modified to the correct terminology
for CINAHL, PsycINFO, EMBASE, and any other databases searched:
("Neoplasms … "[Mesh] OR cancer OR cancers OR neoplasm* OR malignan* OR premalignan* OR
precancerous OR hypertrophy … and after”[tiab] or interrupted time*[tiab] or time
serie*[tiab] or intervention*[tiab]))) AND (("Neoplasms … "[Mesh] OR cancer OR cancers OR
neoplasm* OR malignan* OR premalignan* OR precancerous))
Filters:Publication
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/HZGtYqL_8u57Gkc6YFctmT
August 21, 2018 - infection,
human papillomavirus (HPV) infection (by genotype), precancer (cervical
intraepithelial neoplasia … Fourth, issues regarding HPV-negative cancers and the impli-
cations for the relative effectiveness of … Human papillomavirus genotype–specific
prevalence across the continuum of cervical
neoplasia and cancer … Saraiya M, Unger ER, Thompson TD, et al;
HPV Typing of Cancers Workgroup. … US assessment
of HPV types in cancers: implications for current
and 9-valent HPV vaccines.
-
digital.ahrq.gov/medical-condition/colorectal-cancer
January 01, 2024 - Colorectal Cancer
The relationship between medication beliefs, patient … Support Care Cancer. 2024 Jun 21;32(7):449. doi: 10.1007/s00520-024-08672-3. … Connected Cancer Care: EHR Communication Networks in Virtual Cancer Care Teams - Final Report. … increased cancer knowledge in a randomized controlled trial. … Cancer Control. 2021 Jan-Dec;28:10732748211036783. doi: 10.1177/10732748211036783.
-
digital.ahrq.gov/medical-condition/lung-cancer
January 01, 2024 - Lung Cancer
The relationship between medication beliefs, patient activation … Support Care Cancer. 2024 Jun 21;32(7):449. doi: 10.1007/s00520-024-08672-3. … Patients' perceptions of using technology for self-reporting cancer medication safety events from home … Patient perspectives on a patient-facing tool for lung cancer screening. … Methods for using race and ethnicity in prediction models for lung cancer screening eligibility.
-
digital.ahrq.gov/medical-condition/prostate-cancer
January 01, 2024 - Prostate Cancer
The relationship between medication beliefs, patient … Support Care Cancer. 2024 Jun 21;32(7):449. doi: 10.1007/s00520-024-08672-3. … Patients' perceptions of using technology for self-reporting cancer medication safety events from home … Support Care Cancer. 2024 May 15;32(6):352. doi: 10.1007/s00520-024-08565-5. PMID: 38748294. … Using Electronic Data to Improve Care of Patients With Known or Suspected Cancer - Final Report.
-
effectivehealthcare.ahrq.gov/products/prostate-cancer-test/research-protocol
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs024984-gray-final-report-2019.pdf
January 01, 2019 - Structured Abstract:
Purpose: Many thousands of cancer patients receive tumor genomic testing yearly … Keywords: Cancer genomics, patient education, tool development, eHealth
2. … Cancer is at the leading edge of this revolution and hundreds of thousands of cancer patients receive … tumor genomic testing yearly. … Adult patients with solid tumors at City of Hope (COH) were eligible to
participate if they had somatic